Madison, WINCT07470723Now EnrollingIRB Ready

Heterozygous Familial Hypercholesterolemia (HeFH) Clinical Trial in Madison, WI

Access cutting-edge heterozygous familial hypercholesterolemia (hefh) treatment through this clinical trial at a research site in Madison. Study-provided care at no cost to qualified participants.

Sponsored by University of Wisconsin, Madison

Quick Self-Assessment

See if you qualify for this Madison location

Preparing your pre-screening questions…

Expert Care in Madison

Access heterozygous familial hypercholesterolemia (hefh) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related heterozygous familial hypercholesterolemia (hefh) treatment provided free

Apply for This Madison Location

Check if you qualify for this heterozygous familial hypercholesterolemia (hefh) clinical trial in Madison, WI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Madison

    Convenient for WI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Madison site if eligible
  4. 4Begin participation

About This Heterozygous Familial Hypercholesterolemia (HeFH) Study in Madison

The goal of this clinical trial is to identify different types of Familial Hypercholesterolemia (FH) in infants and newborns. Participants will: * undergo a cheek swab for genetic testing (parents only) * have 5 blood samples collected Participants can expect to be in the trial for 2 years.

Sponsor: University of Wisconsin, Madison

Who Can Participate

Inclusion Criteria

- parent participant:
Individuals in the expectant partnership providing informed consent are at least 18 years of age.
Ability to understand and willingness to sign a written informed consent document.
Willingness to comply with all study procedures and be available for the duration of the study.
Expectant parent (currently pregnant with fetus ≥12 weeks gestation) where one or both partners have been diagnosed with possible or definite HoFH or HeFH based on Dutch Lipid Clinic Network (DLCN) or confirmed diagnosis from a healthcare provider. At minimum, at least one parent with HoFH or HeFH must be willing to consent to study participation. However, both parents will be invited to participate.
Parent(s) commit to using local laboratory services for infant blood samples, with mobile phlebotomy used as an alternative if available in their area. Inclusion Criteria - newborn participant:
Newborn does not have any congenital abnormalities or medical conditions that may interfere with collection of dried blood spot (DBS) specimen and newborn does not require admission to neonatal intensive care unit.

Exclusion Criteria

- parent and newborn participants:
Expectant partnership where neither partner meets diagnostic criteria for HeFH or HoFH.
Parent refuses consent for newborn's study participation.
Newborn has medical condition precluding DBS specimen collection, or a newborn's DBS specimen is not collected by 1 week of age.
Not suitable for study participation due to other reasons at the discretion of the investigators.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Madison?

Yes, this clinical trial (NCT07470723) has an active research site in Madison, WI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Heterozygous Familial Hypercholesterolemia (HeFH) Treatment Options in Madison, WI

If you're searching for heterozygous familial hypercholesterolemia (hefh) treatment options in Madison, WI, this clinical trial (NCT07470723) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Madison research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heterozygous familial hypercholesterolemia (hefh) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all heterozygous familial hypercholesterolemia (hefh) clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Madison, WI

See all heart attack clinical trials recruiting in Madison — not just this study.

Browse Heart Attack Trials in Madison →

Browse More Trials by Condition

Heart Attack TrialsPulmonary Embolism TrialsHigh Cholesterol TrialsEssential Tremor TrialsMyocardial Infarction TrialsFamilial Hypercholesterolemia TrialsFanconi Anemia TrialsAll Conditions →

Ready to Join in Madison?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Madison, WI